IMI to hold fourth quarter 2003 update webcast & conference call
March 04 2004 - 1:49PM
PR Newswire (US)
IMI to hold fourth quarter 2003 update webcast & conference
call TORONTO, March 4 /PRNewswire-FirstCall/ -- IMI International
Medical Innovations Inc. (TSX: IMI, Amex: IME) today announced it
will hold a conference call and webcast on Tuesday, March9, 2004 at
10:30 a.m. (ET) to provide a corporate strategic update for the
fourth quarter of fiscal 2003 and to preview year-end results. The
event will be hosted by Dr. Brent Norton, President and CEO; Ron
Hosking, Vice President and CFO; and Sarah Borg-Olivier, Director,
Communications. Please dial in five minutes prior to start time:
Date: Tuesday, March 9, 2004 Time: 10:30 a.m. ET Webcast:
http://www.imimedical.com/ or http://www.newswire.ca/ Conference
Call Numbers: (416) 640-4127 (Toronto) (800) 814-4857 (North
America) A webcast will be accessible for three months at
http://www.imimedical.com/. A replay of the call willbe available
until March 16, 2004 by dialing (416) 640-1917 (Toronto) or (877)
289-8525 (North America) and entering access code 21041345 followed
by the number sign. IMI is a world leader in predictive medicine,
dedicated to developing rapid, non-invasive tests for the early
detection and monitoring of life-threatening diseases, particularly
cardiovascular disease and cancer. IMI's lead product is a
non-invasive skin test for coronary artery disease. IMI's cancer
products in development include ColorectAlert(TM), a screening test
for colorectal cancer, LungAlert(TM), a screening test for lung
cancer, and a new test for breast cancer. For further information,
please visit the company's website at http://www.imimedical.com/.
DATASOURCE: IMI International Medical Innovations Inc. CONTACT:
please contact Sarah Borg-Olivier, Director, Communications, (416)
222-3449 ext. 27,
Copyright